Back to Authors

Filho, Americo Fernandes

Mayo Clinic

University of Nebraska Medical Center

Citations 2

Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients
Woolley, Susan , Goetz, Ray, Factor‐Litvak, Pam , Murphy, Jennifer , Hupf, Jonathan , Lomen‐Hoerth, Catherine , Andrews, Howard , Heitzman, Daragh, Bedlack, Richard , Katz, Jonathan, Barohn, Richard J., Sorenson, Eric J. , Oskarsson, Björn , Filho, Americo Fernandes, Kasarskis, Edward J. , Mozaffar, Tahseen , Nations, Sharon , Swenson, Andrea , Koczon-Jaremko, Agnes, Christodoulou, Georgia , Mitsumoto, Hiroshi , Garofalo, Diana C. , Sorenson, Eric, Oskarsson, Björn , Bedlack, Richard S , Christodoulou, Georgia

Behavioural Neurology | October 31, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-7

10.1155/2018/5969137 Get It

Objective. To evaluate longitudinal cognitive/behavioral change over 12 months in participants enrolled in the ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS). Methods. We analyzed data from 294 ALS participants, 134 of whom were studied serially. Change over time was evaluated controlling for age, sex, symptom duration, education, race, and ethnicity. Using multiple regression, we evaluated associations among decline in ALS Functional Rating Scale-Revised (ALSFRS-R) scores, forced vital capacity (FVC), and cognitive/behavioral changes. Change in cognitive/behavioral subgroups was assessed using one-way analyses of covariance. Results. Participants with follow-up data had fewer baseline behavior problems compared to patients without follow-up data. We found significant worsening of behavior (ALS Cognitive Behavioral Screen (ALS CBS) behavioral scale, p<0.001; Frontal Behavioral Inventory-ALS (FBI-ALS) disinhibition subscale, p=0.044). Item analysis suggested change in frustration tolerance, insight, mental rigidity, and interests (p<0.05). Changes in ALSFRS-R correlated with the ALS CBS. Worsening disinhibition (FBI-ALS) did not correlate with ALSFRS-R, FVC, or disease duration. Conclusion. We did not detect cognitive change. Behavioral change was detected, and increased disinhibition was found among patients with abnormal baseline behavioral scores. Disinhibition changes did not correlate with disease duration or progression. Baseline behavioral problems were associated with advanced, rapidly progressive disease and study attrition.